Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1257 - 1264 of 12015 results
FDA Delays Enforcement of MoCRA Facility Registration and Cosmetic Product Listing Requirements
November 13, 2023| Blog| Viewpoint
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda
November 10, 2023| Podcast| Viewpoint
The Impact of Venture Capital Funding on Entity Status
November 10, 2023| Blog| Viewpoint
Key Takeaways from the OIG’s New Comprehensive General Compliance Program Guidance
November 10, 2023| Blog| Viewpoint
OMB Releases Draft Guidance to Agencies on Implementing Biden’s AI Executive Order — AI: The Washington Report
November 9, 2023| Advisory| Viewpoint
Court Finds Employer Had Legitimate Reason to Fire Nurse Who Complained of Discrimination
November 9, 2023| News
How Pharma Leaders Talk About Ethics in a Highly Criticized Industry
November 9, 2023| News
All OCR Enforcement Waivers Expired; Are Your Telehealth Services HIPAA Compliant?
November 9, 2023| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|